Please assess the completion status of the following clinical trial:

Trial Title: Hemosonics- VCU Cardiac Surgery Clinical Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Subject is scheduled for cardiac surgery involving bypass circuit~* Subject is older than 18 years~* Subject is willing to participate and he/she has signed a consent form~Exclusion Criteria:~* Subject is unable to provide written informed consent~* Subject is incarcerated at the time of the study~* Subject is affected by any condition that, in the opinion of the surgical team, may pose additional risks~* Patients on emergency cases

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- Cardiac Surgery Patients (Type: None): Single cohort of 50 consecutive cardiac surgery patients undergoing cardiopulmonary bypass. The study compares output of two technologies for determination of point of care coagulation function: thromboelastography (TEG; current care option) and the new technology Sonic Estimation of Elasticity via Resonance (SEER) Sonorheometry

Based on this trial design, predict the completion outcome and termination type (if applicable).